JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A4096 Belinostat (PXD101)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Hydroxamate-type HDAC inhibitor

insoluble in H2O; ≥15.92 mg/mL
A4097 CUDC-907

Target: Histone Deacetylases (HDACs)|PI3K

Summary: Potent PI3K/HDAC inhibitor

≥25.45 mg/mL
A4099 Valproic acid sodium salt (Sodium valproate)

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

≥8.35 mg/mL
A4101 Tubastatin A
6 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥10.75 mg/mL
A4102 CI994 (Tacedinaline)
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥50 mg/mL
A4104 AR-42 (OSU-HDAC42)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,novel and potent

insoluble in EtOH; insoluble in H2O; ≥15.62 mg/mL
A4105 M344
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,potent and cell-permeable